Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:06 AM
Ignite Modification Date:
2025-12-25 @ 2:06 AM
NCT ID:
NCT04698460
Eligibility Criteria:
Inclusion Criteria:
* Signed written informed consent
* Stenosis ≥70% of the LAD and/or ≥50% of left main coronary artery in combination with at least one stenosis ≥70% of the Cx or RCA, suitable for revascularization (decided by a heart team)
* SYNTAX value ≥22.
* Clinical indications for coronary revascularization (angina refractory to optimal medical treatment, ischemia on non-invasive tests, reduced left ventricular ejection fraction)
Exclusion Criteria:
* Previous heart surgery of any kind, including CABG
* Previous surgery involving the left pleural space
* The need for concomitant vascular or other cardiac surgery during index procedure (valve surgery, aortic surgery, left ventricular aneurysmectomy, endarterectomy, etc.)
* Chronic lung disease
* Chronic kidney disease determined as eGFR\<60 ml/min/sq.m
* Failure to give informed consent.
* Life expectancy due to non-heart disease is less than 1 year.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT04698460
Study Brief:
Protocol Section:
NCT04698460